Pharmaceutical drug discovery, development, and access news and insights

Long-Acting Injectable Antiretroviral Therapy Suppresses HIV

by

An ongoing study supported by the NIH in San Francisco assessed the efficacy of long-acting antiretroviral therapy (LA-ART), administered via injection, for treating HIV. The study compared LA-ART to...

Ohio Train Derailment and Chemical Spill Causes Health Hazards

by

On February 3, 2023, a Norfolk Southern train derailed in East Palestine, Ohio, affecting 50 of the 150 cars on the train. The Environmental Protection Agency (EPA) estimates that 20 of the cars...

Reckitt Recalls Plant-Based Infant Formula Due to Health Risk

by

Reckitt, a consumer goods company, recently issued a recall on two batches of its Enfamil 12.9 oz ProSobee Simply Plant-Based Infant Formula, amounting to more than 140,000 cans, due to potential...

Pfizer Eyeing Expedited FDA Approval for RSV Vaccine

by

On Tuesday, Pfizer announced that the FDA accepted for review its Biologics License Application (BLA) for the company’s respiratory syncytial virus (RSV) vaccine candidate RSVpreF. Depending on...

Other Countries Refused 47 FDA-Approved Drugs in the United States

by

An investigation published in JAMA Internal Medicine assessed FDA-approved drugs and regulatory decisions made in other countries. In particular, the study focused on regulation and health technology...

How Structural Racism Has Deterred Minorities from Pursuing Medicine

by

A report from the National Academies of Sciences, Engineering, and Medicine, titled Advancing Antiracism, Diversity, Equity, and Inclusion in STEMM Organizations, explained how structural racism has...

Cleveland Clinic Enrolls Patients in Breast Cancer Vaccine Trial

by

The Cleveland Clinic recently announced that it would begin enrolling patients for its phase 1b breast cancer vaccine study. The study will focus on cancer-free patients at risk of developing cancer,...

Sun Pharmaceutical Industries Acquires Concert Pharma for $576M

by

Last month, Sun Pharma announced that it would pay $8 per share to acquire Concert for a total of $576 million in cash. During the first three quarters of 2022, Concert recorded a net loss of nearly...

CDC Analyzes Sleep Medication Usage by Adults in the United States

by

A recent National Center for Health Statistics (NCHS) analysis determined that 18.4% of adults in the United States took a sleep medication to fall or stay asleep in the past 30 days. The study...

Legalizing Recreational Cannabis May Reduce Some Opioid Distribution

by

Recreational cannabis availability through state-level legalization may contribute to reduced rates of opioid distribution, opioid use disorder (OUD), and overdose. As the opioid epidemic has evolved...

CDC Updates Pediatric Immunization Schedule, Including COVID Vaccine

by

In a 2023 update to the recommended pediatric immunization schedule, the CDC has included recommendations for the COVID-19 vaccine starting at six months. While these guidelines do not force or mandate...

Washington State Takes Regulatory Steps Toward Non-Toxic Cosmetics

by

In House Bill 1047 — introduced on January 9, 2023, and sponsored by representative Sharlett Mena — Washington state has begun to take regulatory steps toward non-toxic cosmetics. The bill...

Envision Pharma Group Acquires OKRA.ai

by

This week, Envision Pharma Group announced that it had acquired OKRA.ai, a leader in artificial intelligence solutions for pharmaceutical operations. The transaction will add OKRA’s founder to...

Global Pharma Healthcare Recalls Artificial Tears Due to Contamination

by

Global Pharma Healthcare has voluntarily recalled multiple batches of artificial tears after patients experienced severe side effects, such as vision loss and mortality. On January 31, 2023, the CDC...

Looking for Solutions Amidst Pharmacist Shortages and Burnout

by

Recent commentary from CVS, Walgreens, Walmart, and other retail pharmacies has included discussions of shortened operation hours as a potential solution for the current pharmacist shortage and...

CDC Analyzes Bivalent mRNA Vaccine Efficacy Against COVID Variants

by

Using data estimates from national pharmacy testing, the CDC analyzed the preliminary efficacy of bivalent mRNA vaccines against multiple COVID variants. The data were collected from December 1, 2022,...

FDA Commissioner Announces New Vision for Human Foods Program

by

Based on data and recommendations from an external review by the Reagan-Udall Foundation and the results of an internal study, FDA commissioner Robert M. Califf, MD, MACC, announced a new vision for...

Senator Targets Amgen and Indivior Acquisitions for Antitrust Action

by

Last week, the Senator from Massachusetts, Elizabeth Warren, penned a letter to the Federal Trade Commission (FTC) where she characterized recent consolidation in the pharmaceutical industry as a...

Abbvie Faces Competitor as a New Humira Biosimilar Comes to Market

by

On January 31, 2023, Amgen announced that its product AMJEVITA, a Humira biosimilar, is now available in the United States. This new availability threatens the stake that AbbVie has held for decades...

FDA Issues Draft Guidance Regarding Lead Levels in Processed Baby Food

by

On January 24, 2024, the FDA issued a new draft guidance regarding lead levels in processed baby food meant for children under two as part of its Closer to Zero initiative. The Closer to Zero...